Literature DB >> 18508927

A novel juxtamembrane domain in tumor necrosis factor receptor superfamily molecules activates Rac1 and controls neurite growth.

Wenjing Ruan1, Christopher T Lee, Julie Desbarats.   

Abstract

Members of the tumor necrosis factor receptor (TNFR) superfamily control cell fate determination, including cell death and differentiation. Fas (CD95) is the prototypical "death receptor" of the TNFR superfamily and signals apoptosis through well established pathways. In the adult nervous system, Fas induces apoptosis in the context of neuropathology such as stroke or amyotrophic lateral sclerosis. However, during nervous system development, Fas promotes neurite growth and branching. The molecular mechanisms underlying Fas-induced process formation and branching have remained unknown to date. Here, we define the molecular pathway linking Fas to process growth and branching in cell lines and in developing neurons. We describe a new cytoplasmic membrane proximal domain (MPD) that is essential for Fas-induced process growth and that is conserved in members of the TNFR superfamily. We show that the Fas MPD recruits ezrin, a molecule that links transmembrane proteins to the cytoskeleton, and activates the small GTPase Rac1. Deletion of the MPD, but not the death domain, abolished Rac1 activation and process growth. Furthermore, an ezrin-derived inhibitory peptide prevented Fas-induced neurite growth in primary neurons. Our results define a new domain, topologically and functionally distinct from the death domain, which regulates neuritogenesis via recruitment of ezrin and activation of Rac1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508927      PMCID: PMC2488301          DOI: 10.1091/mbc.e08-02-0161

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  57 in total

Review 1.  A role for ezrin in a neglected metastatic tumor function.

Authors:  Stefano Fais
Journal:  Trends Mol Med       Date:  2004-06       Impact factor: 11.951

Review 2.  Ezrin/radixin/moesin proteins and Rho GTPase signalling in leucocytes.

Authors:  Aleksandar Ivetic; Anne J Ridley
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

3.  Binding partners L1 cell adhesion molecule and the ezrin-radixin-moesin (ERM) proteins are involved in development and the regenerative response to injury of hippocampal and cortical neurons.

Authors:  Matilda A Haas; James C Vickers; Tracey C Dickson
Journal:  Eur J Neurosci       Date:  2004-09       Impact factor: 3.386

Review 4.  Signalling pathways of the TNF superfamily: a double-edged sword.

Authors:  Bharat B Aggarwal
Journal:  Nat Rev Immunol       Date:  2003-09       Impact factor: 53.106

5.  L1-mediated branching is regulated by two ezrin-radixin-moesin (ERM)-binding sites, the RSLE region and a novel juxtamembrane ERM-binding region.

Authors:  Ling Cheng; Kouichi Itoh; Vance Lemmon
Journal:  J Neurosci       Date:  2005-01-12       Impact factor: 6.167

6.  CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells.

Authors:  Bryan C Barnhart; Patrick Legembre; Eric Pietras; Concetta Bubici; Guido Franzoso; Marcus E Peter
Journal:  EMBO J       Date:  2004-07-22       Impact factor: 11.598

7.  Differential regulation of the mitochondrial and death receptor pathways in neural stem cells.

Authors:  Christoffer Tamm; John D Robertson; Eric Sleeper; Mari Enoksson; Mia Emgård; Sten Orrenius; Sandra Ceccatelli
Journal:  Eur J Neurosci       Date:  2004-05       Impact factor: 3.386

8.  CD95/phosphorylated ezrin association underlies HIV-1 GP120/IL-2-induced susceptibility to CD95(APO-1/Fas)-mediated apoptosis of human resting CD4(+)T lymphocytes.

Authors:  F Luciani; P Matarrese; A M Giammarioli; L Lugini; F Lozupone; C Federici; E Iessi; W Malorni; S Fais
Journal:  Cell Death Differ       Date:  2004-05       Impact factor: 15.828

9.  Identification and relevance of the CD95-binding domain in the N-terminal region of ezrin.

Authors:  Francesco Lozupone; Luana Lugini; Paola Matarrese; Francesca Luciani; Cristina Federici; Elisabetta Iessi; Paola Margutti; Giorgio Stassi; Walter Malorni; Stefano Fais
Journal:  J Biol Chem       Date:  2003-12-15       Impact factor: 5.157

Review 10.  Ezrin...a metastatic detERMinant?

Authors:  Marcello Curto; Andrea I McClatchey
Journal:  Cancer Cell       Date:  2004-02       Impact factor: 31.743

View more
  15 in total

1.  The tumor necrosis factor receptor stalk regions define responsiveness to soluble versus membrane-bound ligand.

Authors:  Christine Richter; Sylvia Messerschmidt; Gerlinde Holeiter; Jessica Tepperink; Sylvia Osswald; Andrea Zappe; Marcus Branschädel; Verena Boschert; Derek A Mann; Peter Scheurich; Anja Krippner-Heidenreich
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

Review 2.  An unexpected turn of fortune: targeting TRAIL-Rs in KRAS-driven cancer.

Authors:  Silvia von Karstedt; Henning Walczak
Journal:  Cell Death Discov       Date:  2020-03-17

Review 3.  Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy.

Authors:  Silvia von Karstedt; Antonella Montinaro; Henning Walczak
Journal:  Nat Rev Cancer       Date:  2017-05-24       Impact factor: 60.716

4.  The death receptor CD95 activates the cofilin pathway to stimulate tumour cell invasion.

Authors:  Ernst J A Steller; Laila Ritsma; Danielle A E Raats; Frederik J H Hoogwater; Benjamin L Emmink; Klaas M Govaert; Jamila Laoukili; Inne H M Borel Rinkes; Jacco van Rheenen; Onno Kranenburg
Journal:  EMBO Rep       Date:  2011-09-01       Impact factor: 8.807

5.  TROY (TNFRSF19) is overexpressed in advanced glial tumors and promotes glioblastoma cell invasion via Pyk2-Rac1 signaling.

Authors:  Vincent M Paulino; Zhongbo Yang; Jean Kloss; Matthew J Ennis; Brock A Armstrong; Joseph C Loftus; Nhan L Tran
Journal:  Mol Cancer Res       Date:  2010-09-29       Impact factor: 5.852

6.  Estrogen inhibits Fas-mediated apoptosis in experimental stroke.

Authors:  Jia Jia; Dening Guan; Wenjing Zhu; Nabil J Alkayed; Michael M Wang; Zichun Hua; Yun Xu
Journal:  Exp Neurol       Date:  2008-10-07       Impact factor: 5.330

7.  TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance.

Authors:  Joseph C Loftus; Harshil Dhruv; Serdar Tuncali; Jean Kloss; Zhongbo Yang; Cassie A Schumacher; Brian Cao; Bart O Williams; Jennifer M Eschbacher; Julianna T D Ross; Nhan L Tran
Journal:  Mol Cancer Res       Date:  2013-05-22       Impact factor: 5.852

Review 8.  Signaling by death receptors in the nervous system.

Authors:  Georg Haase; Brigitte Pettmann; Cédric Raoul; Christopher E Henderson
Journal:  Curr Opin Neurobiol       Date:  2008-06       Impact factor: 6.627

Review 9.  Life in the Fas lane: differential outcomes of Fas signaling.

Authors:  Elizabeth Brint; Grace O'Callaghan; Aileen Houston
Journal:  Cell Mol Life Sci       Date:  2013-04-12       Impact factor: 9.261

Review 10.  The role of tumor necrosis factor receptor superfamily members in mammalian brain development, function and homeostasis.

Authors:  Jason P Twohig; Simone M Cuff; Audrey A Yong; Eddie C Y Wang
Journal:  Rev Neurosci       Date:  2011-08-24       Impact factor: 4.353

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.